dc.creatorPlaza, Nicolás
dc.creatorCastillo, Daniel
dc.creatorPérez Reytor, Diliana
dc.creatorHiguera Guajardo, Gastón
dc.creatorGarcía, Katherine
dc.creatorBastias, Roberto
dc.date.accessioned2018-07-25T19:37:34Z
dc.date.available2018-07-25T19:37:34Z
dc.date.created2018-07-25T19:37:34Z
dc.date.issued2018
dc.identifierElectronic Journal of Biotechnology, 31 (2018): 24–33
dc.identifier10.1016/j.ejbt.2017.10.012
dc.identifierhttps://repositorio.uchile.cl/handle/2250/150275
dc.description.abstractVibrios are common inhabitants of marine and estuarine environments. Some of them can be pathogenic to humans and/or marine animals using a broad repertory of virulence factors. Lately, several reports have indicated that the incidence of Vibrio infections in humans is rising and also in animals constitute a continuing threat for aquaculture. Moreover, the continuous use of antibiotics has been accompanied by an emergence of antibiotic resistance in Vibrio species, implying a necessity for efficient treatments. One promising alternative that emerges is the use of lytic bacteriophages; however, there are some drawbacks that should be overcome to make phage therapy a widely accepted method. In this work, we discuss about the major pathogenic Vibrio species and the progress, benefits and disadvantages that have been detected during the experimental use of bacteriophages to their control.
dc.languageen
dc.publisherUniversidad Católica de Valparaíso
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceElectronic Journal of Biotechnology
dc.subjectAntibiotic
dc.subjectCholera
dc.subjectGram negative bacteria
dc.subjectPhage therapy
dc.subjectVibrio anguillarum
dc.subjectVibrio cholerae
dc.subjectVibrio harveyi
dc.subjectVibrio parahaemolyticus
dc.subjectVibrio
dc.subjectVirulence
dc.titleBacteriophages in the control of pathogenic vibrios
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución